Decreased response of plasma cortisol to intravenous metyrapone in ocular hypertension and primary open-angle glaucoma

Journal of Glaucoma

Volumn 14, Issue 6, 2005, Pages 474-481

  Schwartz, Bernard ^a,b,c   Wysocki, Alice ^b   Qi, Youlin ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Glaucoma Research Foundation   (United States)

^c NONE   (United States)

Author keywords

Intravenous metyrapone; Ocular hypertension; Open angle glaucoma; Plasma 11 deoxycortisol; Plasma cortisol

Indexed keywords

AMITRIPTYLINE; BELLADONNA ALKALOID; CHLOROTHIAZIDE; CHLORTALIDONE; CORTODOXONE; DIAZEPAM; DIGOXIN; GLYCERYL TRINITRATE; HYDROCHLOROTHIAZIDE; HYDROCORTISONE; IMIPRAMINE; ISOSORBIDE; METHYLDOPA; METYRAPONE; PENTAERYTHRITOL; PHENYTOIN; SULFINPYRAZONE; TOLBUTAMIDE;

AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; HORMONE DETERMINATION; HORMONE INHIBITION; HORMONE SYNTHESIS; HUMAN; HYDROCORTISONE BLOOD LEVEL; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MALE; MULTIPLE REGRESSION; MULTIVARIATE ANALYSIS; OPEN ANGLE GLAUCOMA; PRIMARY GLAUCOMA; PRIORITY JOURNAL; VISUAL IMPAIRMENT;

AGED; ENZYME INHIBITORS; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFUSIONS, INTRAVENOUS; INTRAOCULAR PRESSURE; MALE; METYRAPONE; OCULAR HYPERTENSION; PITUITARY-ADRENAL SYSTEM; RADIOIMMUNOASSAY;

EID: 27944448385     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ijg.0000185613.56168.9d     Document Type: Article

References (38)

1. Khasanov N, Pomoshchnikov I. Glucocorticoid function of the adrenal cortex in glaucoma patients. Vestnik Oftal. 1971:234-238.
2. Schwartz B, Levene RZ. Plasma cortisol differences between normal and glaucomatous patients. Arch Ophthalmol. 1972;87:369-378.
3. Ray S, Mehra KS, Misra S, et al. Plasma cortisol in glaucoma. Ann Ophthalmol. 1977;9:1151-1154.
4. Schwartz B, Seddon JM. Increased plasma cortisol levels in ocular hypertension. Arch Ophthalmol. 1981;99:1791-1794.
5. Rozsíval P, Hampl R, Obenberger J, et al. Aqueous humor and plasma cortisol levels in glaucoma and cataract patients. Curr Eye Res. 1981;7:391-396.
6. Schwartz B, McCarty G, Rosner B. Increased plasma free cortisol in ocular hypertension and open-angle glaucoma. Arch Ophthalmol. 1987;105:1060-1065.
7. Metcalf MG, Beaven DW. The metopirone test of pituitary corticotrophin release. Am J Med. 1968;45:176-186.
8. Scheie HG. Width and pigmentation of the angle of the anterior chamber. A system of grading by gonioscopy. Arch Ophthalmol. 1950;58:510-512.
9. Schwartz B. Optic disc changes in ocular hypertension. Surv Ophthalmol. 1980;25:148-154.
10. Mattingly D. A simple fluorometric method for the estimation of free 11-hydroxycorticoids in human plasma. J Clin Pathol. 1962;15:374-379.
11. Spencer-Peet J, Daly JR, Smith V. A simple method for improving the specificity of the fluorometric determination of adrenal corticosteroids in human plasma. J Endocrinol. 1965;31:235-244.
12. Siegel S, Castellan NJ Jr. Non-Parametric Statistics for the Behavioral Sciences. 2nd ed. New York: McGraw-Hill; 1988.
13. Kleinbaum DG, Kupper LL. Applied Regression Analyses and Other Multivariate Methods. 3rd ed. North Scituate, MA: Duxbury Press; 1998.
14. Jubiz W, Matsukura S, Meikle AW, et al. Plasma metyrapone, adrenocorticotropic hormone, cortisol and deoxycortisol levels. Arch Intern Med. 1970;125:468-471.
15. Bertagna X, Raux-Demay M-C, Guilhaume B, et al. Cushing's disease. In: Melmed S, ed. The Pituitary. 2nd ed. Cambridge, MA: Blackwell Publishing; 2002:496-560.
16. Gold EM, DiRaimondo VC, Forsham PH. Quantitation of pituitary corticotropin reserve in man by use of an adrenocortical 11-Beta hydroxylase inhibitor (SE-4885). Metabolism. 1960;9:3-20.
17. Martin MM, Hellman DE. Temporal variation in Su-4885 Responsiveness in man: evidence in support of circadian variation in ACTH secretion. J Clin Endocrinol. 1964;24:253-260.
18. Jubiz W, Matsukura S, Meikle AW, et al. Plasma metyrapone, adrenocorticotropin hormone, cortisol and deoxycortisol levels. Arch Intern Med. 1970;125:468-471.
19. Schwartz B. The response of ocular pressure to corticosteroids. Int Ophthalmol Clin. 1966;6:929-989.
20. Carvalhaes-Neto N, Ramos L, Suchecki D, et al. The effect of hospitalization on the sleep pattern and on cortisol secretion of healthy elderly. Exp Aging Res. 2003;29:425-436.
21. Mason JW, Sachar ED, Fisman JR, et al. Corticosteroid responses to hospital admission. Arch Gen Psychiatry. 1965;13:1-8.
22. Connolly CK, Gore MBR, Stanley N, et al. Single-dose dexamethasone suppression in normal subjects and hospital patients. BMJ. 1968;2:665-667.
23. Levi L, Schwartz B. Decrease of ocular pressure with oral metyrapone. A double-masked crossover trial. Arch Ophthalmol. 1987;105:777-781.
24. Mito T, Shiono T, Kimura R, et al. The effect of oral metyrapone on aqueous humor dynamics in normal human eyes. Acta Ophthalmol (Copenh). 1990;68:582-586.
25. Nieman LK. The evaluation of ACTH-dependent Cushing's Syndrome. Endocrinologist. 1999;9:93-98.
26. Malchoff CD, MacGillivray D, Malchoff DM. Adrenocorticotropic hormone-independent adrenal hyperplasia. Endocrinologist. 1996;6:79-85.
27. Reincke M, Peter M, Sippell WG, et al. Impairment of 11-beta-hydroxylase but not 21-hydroxylase in adrenal "incidentalomas". Eur J Endocrinol. 1997;36:196-200.
28. Dall'Asta C, Barbetta L, Libe R, et al. Coexistence of 21-hydroxylase and 11 beta-hydroxylase deficiency in adrenal incidentalomas and in subclinical Cushing's Syndrome. Horm Res. 2002;57:192-196.
29. Margioris AN, Chrousos GP. Clinical Presentation and Diagnosis of Cushing's Syndrome in Adrenal Disorders. In: Margioris AN, Chrousos GP, eds. Totowa, NY: Humana Press; 2001:279-292.
30. Tatár J. Glaukom bei morbus Cushing. Albrecht v. Graefes Arch Ophthalmol. 1938;139:793-800.
31. Bayer J, Neuner H. Cushing-syndrome und erhölter Augeninendruck. Dtsch Med Wschr. 1967;92:1791-1798.
32. Bayer JM, Neuner H-P. Cushing's syndrome and raised intraocular pressure. Germ Med Mon. 1968;13:205-212.
33. Neuner H. Eye changes in the Cushing-syndrome. Klin Mbl Augenheilk. 1968;152:570-574.
34. Margolis MG. Itsenko-Cushing syndrome and changes in the organ of vision. Oftalmol Zh. 1973;28:391-395.
35. Jonas JB, Huschle O, Koniszewski G, et al. Intraocular pressure in patients with Cushing's disease. Graefes Arch Clin Exp Ophthalmol. 1990;228:407-409.
36. Huschle OK, Jonas JB, Koniszewski G, et al. Glaukom bei Zentralen hypothalamisch-hypophysären Cushing-Syndrome. Fortschr Ophthalmol. 1990;87:453-456.
37. Haas JS, Nootens RH. Glaucoma secondary to benign adrenal adenoma. Am J Ophthalmol. 1974;78:497-500.
38. Robbin DS, Haas JS. A 16-year follow-up in a corticosteroid-sensitive patient with glaucoma secondary to a benign adrenal adenoma. Am J Ophthalmol. 1989;107:293-295.